Skip to main navigation Skip to search Skip to main content

Integration of TaOxwith Bi2S3for Targeted Multimodality Breast Cancer Theranostics

  • Yushen Jin
  • , Chu Tang
  • , Jie Tian*
  • , Bing Shao*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Early identification and treatment of breast cancer is very important for breast conserving therapy and to improve the prognosis and survival rates of patients. Multifunctional nanotheranostic agents are of particular importance in the field of precise nanomedicine, since they can augment the visualization and treatment of cancer. We developed a novel Bi2S3 nanoparticle coated with a hyaluronic acid (HA)-modified tantalum oxide (TaOx) nanoshell (Bi2S3@TaOx-HA). The as-prepared core/shell nanoparticles exhibited a high Bi2S3 nanoparticle loading efficiency of (67 wt %). The TaOx nanoshell exhibited excellent biocompatibility and computed tomography imaging capacity, and the Bi2S3 nanoparticles exhibited an excellent photothermal transducing performance and computed tomography (CT) and photoacoustic imaging capacity. As a result of these merits, the Bi2S3@TaOx core-shell nanoparticles can act as a theranostic agent for CT/photoacoustically monitored enhanced photothermal therapy. These findings will evoke new interest in future cancer therapeutic strategies based on biocompatible functional nanomaterials.

Original languageEnglish
Pages (from-to)161-171
Number of pages11
JournalBioconjugate Chemistry
Volume32
Issue number1
DOIs
StatePublished - 20 Jan 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Integration of TaOxwith Bi2S3for Targeted Multimodality Breast Cancer Theranostics'. Together they form a unique fingerprint.

Cite this